These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 1550081)

  • 1. Late intensification therapy in adult acute lymphoid leukemia. The Southeastern Cancer Study Group Experience.
    Martelo OJ; Omura GA; Gordon DS; Raney M; Bartolucci AA; Vogler WR
    Am J Clin Oncol; 1992 Feb; 15(1):61-8. PubMed ID: 1550081
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Late intensification therapy in adult acute lymphoid leukemia: long-term follow-up of the Southeastern Cancer Study Group experience.
    Omura GA; Vogler WR; Martelo O; Gordon DS; Bartolucci AA
    Leuk Lymphoma; 1994 Sep; 15(1-2):71-8. PubMed ID: 7858504
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized trial of induction therapy (daunorubicin, vincristine, prednisone versus daunorubicin, vincristine, prednisone, cytarabine and 6-thioguanine) in adult acute lymphoblastic leukemia with long-term follow-up: an Eastern Cooperative Oncology Group Study (E3486).
    Wiernik PH; Cassileth PA; Leong T; Hoagland HC; Bennett JM; Paietta E; Oken MM;
    Leuk Lymphoma; 2003 Sep; 44(9):1515-21. PubMed ID: 14565653
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Late intensification chemotherapy has not improved the results of intensive chemotherapy in adult acute lymphoblastic leukemia. Results of a prospective multicenter randomized trial (PETHEMA ALL-89). Spanish Society of Hematology.
    Ribera JM; Ortega JJ; Oriol A; Fontanillas M; Hernández-Rivas JM; Brunet S; García-Conde J; Maldonado J; Zuazu J; Gardella S; Besalduch J; León P; Macià J; Domingo-Albós A; Feliu E; San Miguel JF
    Haematologica; 1998 Mar; 83(3):222-30. PubMed ID: 9573676
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of postinduction intensification treatment with cytarabine and daunorubicin in adult acute lymphocytic leukemia: a prospective randomized clinical trial by Cancer and Leukemia Group B.
    Ellison RR; Mick R; Cuttner J; Schiffer CA; Silver RT; Henderson ES; Woliver T; Royston I; Davey FR; Glicksman AS
    J Clin Oncol; 1991 Nov; 9(11):2002-15. PubMed ID: 1941059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of Mega-COMLA (cyclophosphamide, cytarabine, vincristine, and methotrexate followed by leucovorin and prednisone) plus CHOP (cyclophosphamide, doxorubicin, vincristine, and prednisone) in the treatment of lymphoid neoplasms with very poor prognosis.
    Hainsworth JD; Wolff SN; Stein RS; Greer JP; Cousar JB; Greco FA
    Cancer Treat Rep; 1986 Aug; 70(8):953-8. PubMed ID: 3015406
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extended intrathecal methotrexate may replace cranial irradiation for prevention of CNS relapse in children with intermediate-risk acute lymphoblastic leukemia treated with Berlin-Frankfurt-Münster-based intensive chemotherapy. The Associazione Italiana di Ematologia ed Oncologia Pediatrica.
    Conter V; Aricò M; Valsecchi MG; Rizzari C; Testi AM; Messina C; Mori PG; Miniero R; Colella R; Basso G
    J Clin Oncol; 1995 Oct; 13(10):2497-502. PubMed ID: 7595699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment of acute lymphoblastic leukemia in adults by the modified protocol of L-10M (Sloan-Kettering)].
    Nonaka H; Kuriyama K; Yanagisako T; Satoh T; Miyazaki Y; Nagai K; Tokunaga S; Murata K; Maeda T; Atogami S
    Rinsho Ketsueki; 1990 Jun; 31(6):807-12. PubMed ID: 2214172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Follow-up of the first two successive German multicentre trials for adult ALL (01/81 and 02/84). German Adult ALL Study Group.
    Hoelzer D; Thiel E; Ludwig WD; Löffler H; Büchner T; Freund M; Heil G; Hiddemann W; Maschmeyer G; Völkers B
    Leukemia; 1993 Aug; 7 Suppl 2():S130-4. PubMed ID: 8361217
    [No Abstract]   [Full Text] [Related]  

  • 10. Adult acute lymphocytic leukemia: the Eastern Cooperative Oncology Group experience.
    Cassileth PA; Andersen JW; Bennett JM; Hoagland HC; Mazza JJ; O'Connell MC; Paietta E; Wiernik P
    Leukemia; 1992; 6 Suppl 2():178-81. PubMed ID: 1578927
    [No Abstract]   [Full Text] [Related]  

  • 11. [Acute lymphoblastic leukemia in infants--results of treatment according to infant leukemia protocol--POG 8493].
    Sońta-Jakimczyk D; Armata J; Bogusławska-Jaworska J; Cyklis R; Chybicka A; Grześkowiak-Melanowska J; Radwańska U; Swiatły A; Wieczorek M
    Acta Haematol Pol; 1993; 24(2):131-8. PubMed ID: 8372612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of occult or late overt testicular relapse in children with acute lymphoblastic leukemia: a Pediatric Oncology Group study.
    Wofford MM; Smith SD; Shuster JJ; Johnson W; Buchanan GR; Wharam MD; Ritchey AK; Rosen D; Haggard ME; Golembe BL
    J Clin Oncol; 1992 Apr; 10(4):624-30. PubMed ID: 1548525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early intensification and short-term maintenance chemotherapy does not prolong survival in acute myelogenous leukemia.
    Kantarjian HM; Keating MJ; Walters RS; McCredie KB; Bodey GP; Freireich EJ
    Cancer; 1986 Oct; 58(8):1603-8. PubMed ID: 3463390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of two regimens for high-risk acute lymphocytic leukemia in childhood. A Pediatric Oncology Group Study.
    van Eys J; Berry D; Crist W; Doering E; Fernbach D; Pullen J; Shuster J; Wharam M
    Cancer; 1989 Jan; 63(1):23-9. PubMed ID: 2910421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early intensification followed by allo-BMT or auto-BMT or a second intensification in adult ALL: a randomized multicenter study.
    Bernasconi C; Lazzarino M; Morra E; Alessandrino EP; Pagnucco G; Resegotti L; Locatelli F; Ficarra F; Bacigalupo A; Carella AM
    Leukemia; 1992; 6 Suppl 2():204-8. PubMed ID: 1578935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclic combination chemotherapy for acute lymphoblastic leukemia recurring after elective cessation of therapy.
    Pui CH; Bowman WP; Ochs J; Dodge RK; Rivera GK
    Med Pediatr Oncol; 1988; 16(1):21-6. PubMed ID: 3422333
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment outcome of adult acute lymphocytic leukemia with VPD(L) regimen: analysis of prognostic factors.
    Park SR; Kim JH; Kim DY; Lee S; Lee SY; Choi IS; Yoon SS; Park S; Kim BG; Kim NK
    Korean J Intern Med; 2003 Mar; 18(1):21-8. PubMed ID: 12760264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of intensification and maintenance programs in the treatment of acute lymphoblastic leukemia.
    Sackmann-Muriel F; Svarch E; Eppinger-Helft M; Braier JL; Pavlovsky S; Guman L; Vergara B; Ponzinibbio C; Failace R; Garay GE; Bugnard E; Ojeda FG; De Bellis R; de Sijvarger SR; Saslavsky J
    Cancer; 1978 Oct; 42(4):1730-40. PubMed ID: 101296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment of acute lymphoblastic leukemia in low risk adults].
    Rubio ME; Avilés A; Tripp F; Murillo E; González-Llaven J
    Arch Invest Med (Mex); 1989; 20(1):33-7. PubMed ID: 2669671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term follow-up results of adult patients with acute lymphocytic leukemia or lymphoblastic lymphoma treated with short-term, alternating non-cross-resistant chemotherapy: Japan Clinical Oncology Group Study 8702. Lymphoma Study Group.
    Kobayashi T; Tobinai K; Shimoyama M; Mikuni C; Konda S; Kozuru M; Araki K; Sai T; Fukuhara S; Matsumoto M; Aoki I; Deura K; Oyama A; Hotta T; Abe T; Toki H; Nagai M; Fukuda H; Niimi M; Yamaguchi N; Tajima K; Shirakawa S
    Jpn J Clin Oncol; 1999 Jul; 29(7):340-8. PubMed ID: 10470659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.